Literature DB >> 2438776

In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-AZA-2'-deoxycytidine.

N Onetto, R L Momparler, L F Momparler, M Gyger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2438776

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.

Authors:  J Laliberté; V E Marquez; R L Momparler
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.

Authors:  Hongmei Ruan; Songbo Qiu; Brian C Beard; Margaret E Black
Journal:  Protein Eng Des Sel       Date:  2016-05-08       Impact factor: 1.650

3.  Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.

Authors:  Sara M Fitzgerald; Rakesh K Goyal; William R A Osborne; Jennifer D Roy; John W Wilson; R E Ferrell
Journal:  Hum Genet       Date:  2006-01-31       Impact factor: 4.132

4.  Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia.

Authors:  Richard L Momparler
Journal:  Exp Hematol Oncol       Date:  2013-08-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.